Incidence rates and trends of childhood urinary tract infections and antibiotic prescribing: registry-based study in general practices (2000 to 2020).
Anti-bacterial agents
General practice
General practitioners
Incidence
Retrospective studies
Urinalysis
Urinary tract infections
Journal
BMC primary care
ISSN: 2731-4553
Titre abrégé: BMC Prim Care
Pays: England
ID NLM: 9918300889006676
Informations de publication
Date de publication:
20 07 2022
20 07 2022
Historique:
received:
14
03
2022
accepted:
30
06
2022
entrez:
20
7
2022
pubmed:
21
7
2022
medline:
23
7
2022
Statut:
epublish
Résumé
To improve the management of childhood urinary tract infections, it is essential to understand the incidence rates, testing and treatment strategy. A retrospective study using data from 45 to 104 general practices (2000 to 2020) in Flanders (Belgium). We calculated the incidence rates (per 1000 person-years) of cystitis, pyelonephritis, and lab-based urine tests per age (< 2, 2-4, 5-9 and 10-18 years)) and gender in children and performed an autoregressive time-series analysis and seasonality analysis. In children with UTI, we calculated the number of lab-based urine tests and antibiotic prescriptions per person-year and performed an autoregressive time-series analysis. There was a statistically significant increase in the number of UTI episodes from 2000 to 2020 in each age group (p < 0.05), except in boys 2-4 years. Overall, the change in incidence rate was low. In 2020, the incidence rates of cystitis were highest in girls 2-4 years old (40.3 /1000 person-years 95%CI 34.5-46.7) and lowest in boys 10-18 (2.6 /1000 person-years 95%CI 1.8-3.6) The incidence rates of pyelonephritis were highest in girls 2-4 years (5.5, 95%CI 3.5-8.1 /1000 person-years) and children < 2 years of age (boys: 5.4, 95%CI 3.1-8.8 and girls: 4.9, 95%CI 2.7-8.8 /1000 person-years). In children 2-10 years, there was an increase in number of lab-based urine tests per cystitis episode per year and a decrease in total number of electronic antibiotic prescriptions per cystitis episode per year, from 2000 to 2020. In children with cystitis < 10 years in 2020, 51% (95%CI 47-56%) received an electronic antibiotic prescription, of which the majority were broad-spectrum agents. Over the last 21 years, there was a slight increase in the number of UTI episodes diagnosed in children in Flemish general practices, although the overall change was low. More targeted antibiotic therapy for cystitis in accordance with clinical guidelines is necessary to reduce the use of broad-spectrum agents in children below 10 years.
Sections du résumé
BACKGROUND
To improve the management of childhood urinary tract infections, it is essential to understand the incidence rates, testing and treatment strategy.
METHODS
A retrospective study using data from 45 to 104 general practices (2000 to 2020) in Flanders (Belgium). We calculated the incidence rates (per 1000 person-years) of cystitis, pyelonephritis, and lab-based urine tests per age (< 2, 2-4, 5-9 and 10-18 years)) and gender in children and performed an autoregressive time-series analysis and seasonality analysis. In children with UTI, we calculated the number of lab-based urine tests and antibiotic prescriptions per person-year and performed an autoregressive time-series analysis.
RESULTS
There was a statistically significant increase in the number of UTI episodes from 2000 to 2020 in each age group (p < 0.05), except in boys 2-4 years. Overall, the change in incidence rate was low. In 2020, the incidence rates of cystitis were highest in girls 2-4 years old (40.3 /1000 person-years 95%CI 34.5-46.7) and lowest in boys 10-18 (2.6 /1000 person-years 95%CI 1.8-3.6) The incidence rates of pyelonephritis were highest in girls 2-4 years (5.5, 95%CI 3.5-8.1 /1000 person-years) and children < 2 years of age (boys: 5.4, 95%CI 3.1-8.8 and girls: 4.9, 95%CI 2.7-8.8 /1000 person-years). In children 2-10 years, there was an increase in number of lab-based urine tests per cystitis episode per year and a decrease in total number of electronic antibiotic prescriptions per cystitis episode per year, from 2000 to 2020. In children with cystitis < 10 years in 2020, 51% (95%CI 47-56%) received an electronic antibiotic prescription, of which the majority were broad-spectrum agents.
CONCLUSIONS
Over the last 21 years, there was a slight increase in the number of UTI episodes diagnosed in children in Flemish general practices, although the overall change was low. More targeted antibiotic therapy for cystitis in accordance with clinical guidelines is necessary to reduce the use of broad-spectrum agents in children below 10 years.
Identifiants
pubmed: 35858840
doi: 10.1186/s12875-022-01784-x
pii: 10.1186/s12875-022-01784-x
pmc: PMC9301837
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
177Informations de copyright
© 2022. The Author(s).
Références
Br Med J. 1979 May 19;1(6174):1330-2
pubmed: 445055
J Eval Clin Pract. 2005 Feb;11(1):73-6
pubmed: 15660540
BMC Pediatr. 2006 Apr 04;6:10
pubmed: 16584577
BMJ. 2018 Nov 28;363:k4666
pubmed: 30487169
PLoS Med. 2015 Oct 06;12(10):e1001885
pubmed: 26440803
Pediatrics. 2011 Jun;127(6):1027-33
pubmed: 21555502
JAMA Pediatr. 2019 Oct 01;173(10):949-952
pubmed: 31381021
Ann Fam Med. 2021 Sep-Oct;19(5):437-446
pubmed: 34546950
BMC Pediatr. 2022 Jan 3;22(1):12
pubmed: 34980037
BMJ. 1988 Aug 13;297(6646):450-2
pubmed: 3139139
BMC Fam Pract. 2007 Mar 13;8:9
pubmed: 17355617
Pediatrics. 2010 Apr;125(4):664-72
pubmed: 20194282
Br Med J. 1966 Mar 12;1(5488):631-5
pubmed: 5908707
J Pediatr Pharmacol Ther. 2019 Jan-Feb;24(1):39-44
pubmed: 30837813
Fam Pract. 2017 Apr 1;34(2):169-174
pubmed: 28122841
J R Coll Gen Pract. 1977 Nov;27(184):678-83
pubmed: 616858
Acta Paediatr Scand Suppl. 1974;(252):1-20
pubmed: 4618418
BMC Med Inform Decis Mak. 2014 Jun 06;14:48
pubmed: 24906941
Acta Paediatr. 1998 May;87(5):549-52
pubmed: 9641738
JMIR Med Inform. 2019 Jul 26;7(3):e11929
pubmed: 31350839
Pediatrics. 2016 Dec;138(6):
pubmed: 27940735
BMJ. 1994 Sep 10;309(6955):631-4
pubmed: 7695692